COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPRNewsWire • 04/04/24
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 03/26/24
CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, CaliforniaPRNewsWire • 01/08/24
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast ImplantsPRNewsWire • 01/02/24
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 11/09/23
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal FillerPRNewsWire • 11/01/23
CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability InitiativePRNewsWire • 09/21/23
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 MillionPRNewsWire • 08/24/23
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 08/09/23
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 08/09/23
CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration AgreementPRNewsWire • 06/26/23
CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate UpdatePRNewsWire • 05/24/23
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 05/02/23
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and OrgansBusiness Wire • 04/04/23
Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate UpdatePRNewsWire • 03/29/23
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATIONPRNewsWire • 03/14/23